Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus
Dereje A. Negatu, Andreas Beuchel, Abdeldjalil Madani, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 8
Open Access | Times Cited: 22

Showing 22 citing articles:

Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers
Mark J. Mitton‐Fry, Jason E. Cummings, Yanran Lu, et al.
ACS Infectious Diseases (2025) Vol. 11, Iss. 2, pp. 474-482
Closed Access | Times Cited: 1
A laboratory perspective on Mycobacterium abscessus biofilm culture, characterization and drug activity testing
Henriëtte Margarethe Meliefste, Saskia E. Mudde, Nicole C. Ammerman, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach
Baji Baba Shaik, Kimeshni Moodley, Safiyah Ghumran, et al.
Medicinal Research Reviews (2025)
Closed Access
Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease
Jickky Palmae Sarathy, Min Xie, Chui Fann Wong, et al.
ACS Infectious Diseases (2025)
Open Access
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease
Dereje A. Negatu, Matthew D. Zimmerman, Véronique Dartois, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 21
In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus
Wassihun Wedajo Aragaw, Nicole Cotroneo, S. Stokes, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus In Vitro
Jickky Palmae Sarathy, Matthew D. Zimmerman, Martin Gengenbacher, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 12
Open Access | Times Cited: 14
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate
Min Xie, Uday S. Ganapathy, Tian Lan, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 9
Open Access | Times Cited: 8
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
Uday S. Ganapathy, Rubén González del Río, Mónica Cacho-Izquierdo, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 12
Open Access | Times Cited: 19
Why Matter Matters: Fast-Tracking Mycobacterium abscessus Drug Discovery
Uday S. Ganapathy, Thomas Dick
Molecules (2022) Vol. 27, Iss. 20, pp. 6948-6948
Open Access | Times Cited: 13
Characterization of In Vitro Resistance to Linezolid in Mycobacterium abscessus
Dereje A. Negatu, Wassihun Wedajo Aragaw, Véronique Dartois, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 7
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division
Giulia Degiacomi, Laurent R. Chiarelli, Olga Riabova, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107278-107278
Open Access | Times Cited: 2
Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice
Wassihun Wedajo Aragaw, Christine Roubert, Evelyne Fontaine, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 66, Iss. 1
Open Access | Times Cited: 16
Structure–Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors
Andreas Beuchel, Dina Robaa, Dereje A. Negatu, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 3, pp. 417-427
Open Access | Times Cited: 9
Determination of bactericidal activity against 3HC-2-Tre-labelled Mycobacterium abscessus (Mycobacteroides abscessus) by automated fluorescence microscopy
Lea Mann, Fabienne Siersleben, Markus Lang, et al.
Journal of Microbiological Methods (2024) Vol. 224, pp. 107002-107002
Open Access | Times Cited: 1
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
Abdeldjalil Madani, Dereje A. Negatu, Abdellatif El Marrouni, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 9
Open Access | Times Cited: 7
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research
Mario Cocorullo, C Bettoni, Sara Foiadelli, et al.
Future Pharmacology (2023) Vol. 3, Iss. 3, pp. 637-663
Open Access | Times Cited: 3
Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease
Dereje A. Negatu, Wassihun Wedajo Aragaw, Tewodros Tariku Gebresilase, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 69, Iss. 1
Open Access
Inhibition of Human Coronaviruses by Piperidine-4-Carboxamides
Xin Guo, Ayan Ghosh, Halli E. Miller, et al.
Infectious Diseases Diagnosis & Treatment (2022) Vol. 6, Iss. 3
Open Access | Times Cited: 2
Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
Abdeldjalil Madani, Dereje A. Negatu, Abdellatif El Marrouni, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
A novel chemogenomic discovery platform identifies bioactive hits with rapid bactericidal activity against Mycobacteroides Abscessus
Gaelle Makafe, Laura Cole, Alan Roberts, et al.
Tuberculosis (2023) Vol. 139, pp. 102317-102317
Open Access
Strongly bactericidal all-oral β-lactam combinations for the treatment of Mycobacterium abscessus lung disease
Dereje A. Negatu, Matthew D. Zimmerman, Véronique Dartois, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top